Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study
- 79 Downloads
Objective: Alendronate and calcitonin are antiresorptive drugs that were used for the treatment of postmenopausal osteoporosis and were shown to increase bone mineral density (BMD). However, the effect of both drugs in daily clinical practice may differ from that observed in clinical trials.
Method: About 50 postmenopausal osteoporotic women were observed during their first year of treatment. Among them, 32 patients used alendronate and 18 used calcitonin. Lumbar spine and femoral neck BMD were measured by dual energy X-ray absorptiometry (DXA) at baseline and after 1 year of therapy. Biochemical markers (B-ALP – bone-specific alkaline phosphatase, OTC – osteocalcin and DPD/UCr – deoxypyridinoline/creatinine ratio) of bone metabolism were measured at baseline and 6 months later. Patient compliance was assumed by tablet counting and verified at interview. Each patient was further questioned about her attitude towards the treatment, as well as her dairy product intake, physical activity, use of other medications, smoking and social status.
Main outcome measure: (1) Annual percent change in BMD in lumbar spine and femoral neck after the one-year treatment with either alendronate or calcitonin. (2) The change in biochemical markers of bone turnover.
Results: The lumbar spine BMD significantly increased by 7.0% (P < 0.001), the femoral neck BMD by 4.3% (P < 0.01). OTC, B-ALP and DPD/UCr decreased significantly during the therapy with alendronate. Compliance with therapy was 79% (95% CI 68–90%). In the calcitonin-treated group, the lumbar spine BMD significantly increased by 3.1 % (P < 0.05), while the femoral neck BMD remained unchanged. OTC, B-ALP and DPD/UCr did not change significantly during the treatment with calcitonin. Compliance with calcitonin therapy was 87% (95% CI 63–110%). The annual change of BMD in both treatment groups was independent on all questioned factors.
Conclusion: In daily practice, alendronate enhanced significantly BMD both in lumbar spine and femoral neck. Calcitonin showed increase only in the lumbar spine BMD.
KeywordsAlendronate Bone mineral density Calcitonin Czech Republic Observational study Postmenopausal osteoporosis
Unable to display preview. Download preview PDF.
- NIH Consensus Statement.2000Osteoporosis Prevention, Diagnosis, and TherapyMarch 27–29.17136Google Scholar
- Pols, HAP, Felsenberg, D, Hanley, DA, Stepan, J, Munoz-Torres, M, Wilkin, TJ, et al. 1999Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT studyOsteoporos Int94618PubMedGoogle Scholar
- Body, JJ, Gregory, AG, Scheele, WH, Kulkarni, PM, Miller, PD, Peretz, A, et al. 2002A randomized double-blind trial to compare the efficacy of teriparatide (recombinant human parathyroid hormone (1–34)) with alendronate in postmenopausal women with osteoporosisJ Clin Endocrinol Metab87452835PubMedGoogle Scholar
- Murphy, MG, Weiss, S, McClung, M, Schnitzer, T, Cerchio, K, Connor, J, et al. 2001Effect of alendronate and MK-667 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic womenJ Clin Endocrinol Metab86111625CrossRefPubMedGoogle Scholar
- Adami S, Baroni MC, Broggini M, Carratelli L, Caruso I, Gnessi L et al. (1993). Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin. Osteoporos Int (Suppl 3): S21–S27Google Scholar
- Kapetanos G, Symeonides PP, Dimitriou C, Karakatsanis K, Potoupnis M. (1997). A double blind study of intranasal calcitonin for established postmenopausal osteoporosis. Acta Orthop Scand (Suppl 275): 108–11Google Scholar
- Overgaard, K, Lindsay, R, Christiansen, C. 1995Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year studyClin Ther55826Google Scholar